Nivolumab in patients with relapsed or refractory lymphoid malignancies and classical Hodgkin lymphoma: Updated safety and efficacy results of a phase 1 study (CA209-039) Meeting Abstract
| Authors: | Armand, P.; Timmerman, J.; Lesokhin, A.; Halwani, A.; Millenson, M.; Schuster, S.; Gutierrez, M.; Scott, E.; Cattry, D.; Freeman, G.; Chapuy, B.; Ligon, A.; Rodig, S.; Zhu, L.; Grosso, J.; Simon, J.; Shipp, M.; Cohen, A.; Lebovic, D.; Dhodapkar, M.; Avigan, D.; Ansell, S.; Borrello, I. |
| Abstract Title: | Nivolumab in patients with relapsed or refractory lymphoid malignancies and classical Hodgkin lymphoma: Updated safety and efficacy results of a phase 1 study (CA209-039) |
| Meeting Title: | 20th Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 100 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2015 Jun 11-14 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2015-06-01 |
| Start Page: | 323 |
| Language: | English |
| ACCESSION: | WOS:000361204902312 |
| PROVIDER: | wos |
| PMCID: | PMC4480587 |
| Notes: | Meeting Abstract: S808 -- Source: Wos |
